Browsing: Pharmaceutical Strategies Group
More employers and health plans are balking at paying for costly GLP-1 drugs like Ozempic, Zepbound and Wegovy for weight…
Specialty drugs are an increasing worry for health plans and employers as new and innovative therapies enter the U.S. market…